BIO Comments to FDA on their Workshop to Enhance Clinical Study Diversity
January 29, 2024
Following the FDA Workshop to Enhance Clinical Study Diversity on November 29-30, 2023, BIO submits specific comments per the request for information (FDA-2023-N-2462).
Download Full Comments Below
In response to the request for information and comments, BIO submitted general comments and recommended edits (FDA-2023-D-2318)